Researchers determined the anti-fibrotic efficacy and potential mechanisms of bromodomain and extra-terminal domain proteins inhibition in systemic sclerosis.
[JCI Insight]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.